PriceTargets.com logo

Emerald Health Therapeutics - EMH Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: C$0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$0.26 As of 04/27/2021 12:59 AM ET
▼ -0.01 (-3.77%)

This chart shows the closing price for EMH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Emerald Health Therapeutics Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EMH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EMH

Analyst Price Target is C$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Emerald Health Therapeutics in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a -100.00% upside from the last price of C$0.26.

This chart shows the closing price for EMH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Emerald Health Therapeutics. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/31/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/26/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/23/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/11/2019Jefferies Financial GroupLower TargetC$4.20 ➝ C$1.50
5/3/2019Jefferies Financial GroupLower TargetC$4.30 ➝ C$4.20
(Data available from 4/23/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/26/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/26/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/25/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/25/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/24/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/23/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/24/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/23/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Emerald Health Therapeutics logo
Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.
Read More

Today's Range

Now: C$0.26
Low: C$0.25
High: C$0.27

50 Day Range

MA: C$0.26
Low: C$0.26
High: C$0.26

52 Week Range

Now: C$0.26
Low: C$0.15
High: C$0.53

Volume

384,329 shs

Average Volume

644,760 shs

Market Capitalization

C$52.28 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Emerald Health Therapeutics?

The following Wall Street sell-side analysts have issued stock ratings on Emerald Health Therapeutics in the last year:
View the latest analyst ratings for EMH.

What is the current price target for Emerald Health Therapeutics?

0 Wall Street analysts have set twelve-month price targets for Emerald Health Therapeutics in the last year. has the lowest price target set, forecasting a price of C$10,000,000.00 for Emerald Health Therapeutics in the next year.
View the latest price targets for EMH.

What is the current consensus analyst rating for Emerald Health Therapeutics?

Emerald Health Therapeutics currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for EMH.

What other companies compete with Emerald Health Therapeutics?

Other companies that are similar to Emerald Health Therapeutics include ProMIS Neurosciences, Small Pharma, BriaCell Therapeutics, Microbix Biosystems and Helix BioPharma. Learn More about companies similar to Emerald Health Therapeutics.

How do I contact Emerald Health Therapeutics' investor relations team?

Emerald Health Therapeutics' physical mailing address is 4420 West Saanich Road, Rpo Royal Oak PO Box 24076, VICTORIA, BC V8Z 7E7, Canada. The company's listed phone number is +1-250-8189838. The official website for Emerald Health Therapeutics is www.emerald.care. Learn More about contacing Emerald Health Therapeutics investor relations.